Glucose metabolism and insulin signaling pathways

Glucose metabolism and insulin signaling pathways represent a complex network of intracellular signaling and metabolic reactions essential for maintaining energy homeostasis. The process is initiated when insulin binds to the insulin receptor, a transmembrane tyrosine kinase, leading to the activation of downstream effectors like Phosphoinositide 3-kinase (PI3K) and Protein Kinase B (AKT) [1][2]. These signals promote the translocation of glucose transporter 4 (GLUT4) to the cell membrane, facilitating glucose uptake into muscle and adipose tissues while inhibiting hepatic glucose production [3]. Dysregulation of these pathways, often characterized by insulin resistance, is the primary driver of Type 2 Diabetes Mellitus and metabolic syndrome [4]. While the pathway as a whole is not a single therapeutic target, many of its individual components, such as enzymes and receptors, serve as critical sites for pharmacological intervention to manage blood sugar levels [5].

Other names

Insulin signaling cascadeGlucose homeostasisGlycolysis and gluconeogenesis pathwaysInsulin-mediated glucose uptake

Drugs affecting these pathways act through diverse mechanisms including insulin receptor agonism, activation of AMP-activated protein kinase (AMPK), modulation of PPAR-gamma transcription, inhibition of dipeptidyl peptidase-4 (DPP-4), inhibition of sodium-glucose cotransporter 2 (SGLT2), and activation of glucagon-like peptide-1 (GLP-1) receptors to enhance insulin sensitivity or reduce glucose levels.